Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gailani

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Haematologica|September 5, 2007
Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasmaPatricia J Anderson, David Gailani, Hendrik B Feys, et al.
Blood|April 9, 2009
Factor XI contributes to thrombin generation in the absence of factor XIIDmitri V Kravtsov, Anton Matafonov, Erik I Tucker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocoliticaDeyan Luo, Frank M Szaba, Lawrence W Kummer, et al.
The Journal of Biological Chemistry|September 11, 2012
A sequential mechanism for exosite-mediated factor IX activation by factor XIaYipeng Geng, Ingrid M Verhamme, Amanda Messer, et al.
Blood|March 24, 2012
Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsisErik I Tucker, Norah G Verbout, Philberta Y Leung, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 2016
Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout MiceReut Shnerb Ganor, Dror Harats, Ginette Schiby, et al.
Journal of Thrombosis and Haemostasis : JTH|March 2, 2023
A site on factor XII required for productive interactions with polyphosphateAleksandr Shamanaev, Maxim Litvak, Qiufang Cheng, et al.
JAMA Oncology|September 16, 2016
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A ReviewWeijuan Li, David Garcia, R Frank Cornell, et al.
Blood|January 11, 2017
Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activationIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.
Elife|March 8, 2021
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lungAlan E Mast, Alisa S Wolberg, David Gailani, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Haematologica|September 5, 2007
Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasmaPatricia J Anderson, David Gailani, Hendrik B Feys, et al.
Blood|April 9, 2009
Factor XI contributes to thrombin generation in the absence of factor XIIDmitri V Kravtsov, Anton Matafonov, Erik I Tucker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocoliticaDeyan Luo, Frank M Szaba, Lawrence W Kummer, et al.
The Journal of Biological Chemistry|September 11, 2012
A sequential mechanism for exosite-mediated factor IX activation by factor XIaYipeng Geng, Ingrid M Verhamme, Amanda Messer, et al.
Blood|March 24, 2012
Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsisErik I Tucker, Norah G Verbout, Philberta Y Leung, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 2016
Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout MiceReut Shnerb Ganor, Dror Harats, Ginette Schiby, et al.
Journal of Thrombosis and Haemostasis : JTH|March 2, 2023
A site on factor XII required for productive interactions with polyphosphateAleksandr Shamanaev, Maxim Litvak, Qiufang Cheng, et al.
JAMA Oncology|September 16, 2016
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A ReviewWeijuan Li, David Garcia, R Frank Cornell, et al.
Blood|January 11, 2017
Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activationIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.
Elife|March 8, 2021
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lungAlan E Mast, Alisa S Wolberg, David Gailani, et al.
Pageof 17